Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Podiatric Medicine topic
No spam. Unsubscribe anytime.
Podiatric Medical Board reports modernization steps, flags budget pressure and parity issues
Summary
The Podiatric Medical Board told legislators it has modernized renewal rules, expanded residency approvals and worked to streamline licensing, but said fee and staffing constraints threaten program sustainability; stakeholders urged reimbursement and parity changes for podiatrists.
The Podiatric Medical Board of California told a joint Assembly–Senate sunset review hearing that it has updated licensure renewal requirements, improved licensing timelines through automation and expanded residency opportunities, but that a small licensee base and rising enforcement costs are straining its finances.
Board President Dr. Carolyn McAloon said the board sponsored and supported several legislative changes — including AB 826 updating renewal requirements, AB 834 on partnership agreements and AB 1704 modernizing limited radiographic permits — and is pursuing DEI work and hybrid meetings to reduce costs. “We eliminated outdated burdensome license renewal requirements,” McAloon said.
Why it matters: Committee members asked whether the board’s small staff and licensee pool are financially sustainable and how podiatrists can obtain reimbursement parity with MDs and DOs. The board said investigations and pro rata costs within the Department of Consumer Affairs are fixed and that fee increases or other revenue options will likely be needed.
Supporting details: The board reported approving an additional three‑year podiatric residency program and adding six new podiatric clinical experts to support complaint review. The board noted reliance on licensure revenue and said outreach and school/residency engagement have been constrained by budget limits.
Ending: Stakeholders including the California Podiatric Medical Association urged attention to practice issues — reimbursement, scope and recognition of DPMs’ clinical roles — while the board committed to further discussion and to returning with follow‑up analysis on enforcement timelines and shared services.
